alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
# C_2021252EN.01001702.xml

| 28.6.2021 | EN | Official Journal of the European Union | C 252/17 |
| --- | --- | --- | --- |

28.6.2021

EN

Official Journal of the European Union

C 252/17

---

Request for a preliminary ruling from the Budapest Környéki Törvényszék (Hungary) lodged on 28 April 2021 — WD v Agrárminiszter

(Case C-273/21)

(2021/C 252/23)

Language of the case: Hungarian

Referring court

Budapest Környéki Törvényszék

Parties to the main proceedings

Applicant: WD

Defendant: Agrárminiszter

Question referred

By its single question, the referring court seeks clarification as to whether Article 32(2)(a) and (b) of Regulation (EU) No 1307/2013 (1) must be interpreted as meaning that an area, classified in the land registry as ‘aerodrome withdrawn from agricultural use’, and where there is no activity associated with an aerodrome, must be considered as predominantly used for agricultural activities if animals are kept for farming purposes in that area.

---

(1)  Regulation (EU) No 1307/2013 of the European Parliament and of the Council of 17 December 2013 establishing rules for direct payments to farmers under support schemes within the framework of the common agricultural policy and repealing Council Regulation (EC) No 637/2008 and Council Regulation (EC) No 73/2009 (OJ 2013 L 347, p. 608).

---
UNPUBLISHED

UNITED STATES COURT OF APPEALS

FOR THE FOURTH CIRCUIT

No. 14-7232

RONALD N. HASKINS,

Plaintiff - Appellant,

v.

BRIAN K. HAWK, Correctional Officer,

Defendant - Appellee.

Appeal from the United States District Court for the District of 

Maryland, at Baltimore. Timothy J. Sullivan, Magistrate Judge. 

(1:11-cv-02000-TJS)

Submitted: May 19, 2015 Decided: May 21, 2015

Before NIEMEYER and HARRIS, Circuit Judges, and DAVIS, Senior 

Circuit Judge.

Affirmed by unpublished per curiam opinion.

Ronald N. Haskins, Appellant Pro Se. Douglas F. Gansler, OFFICE 

OF THE ATTORNEY GENERAL OF MARYLAND, Baltimore, Maryland; Laura 

Mullally, Assistant Chief Counsel, Pikesville, Maryland, for 

Appellee.

Unpublished opinions are not binding precedent in this circuit.
2

PER CURIAM:

Ronald N. Haskins appeals from the district court’s order, 

following a jury verdict, entering judgment in favor of the 

Defendant in Haskins’ 42 U.S.C. § 1983 (2012) suit. We have 

reviewed the record and find no reversible error. Accordingly, 

we affirm.*

 We dispense with oral argument because the facts and 

legal contentions are adequately presented in the materials 

before this court and argument would not aid the decisional 

process.

AFFIRMED

 * We also deny Haskins’ motion for injunctive relief as moot 

and not in compliance with Fed. R. App. P. 8.
<PAGE>
 
                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                              WASHINGTON, DC 20549

   
                                  FORM 10-Q/A
    

[X]  QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE
     ACT OF 1934

                  For the quarterly period ended June 30, 1998

                                       Or


[ ]  TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES
     EXCHANGE ACT OF 1934

            For the transition period from ___________ to ___________
                       Commission File Number____________

                          SUMMIT MEDICAL SYSTEMS, INC.

             (Exact name of registrant as specified in its charter)


           MINNESOTA                                41-1545493
(State or other jurisdiction of               (IRS Employer ID No.)
 incorporation or organization)


                             10900 RED CIRCLE DRIVE
                                    SUITE 100
                              MINNETONKA, MN 55343
                                  612-939-2200
                  (Address including zip code, of Registrant's
                    principal executive offices and telephone
                          number, including area code)


Indicate by check mark whether the registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the preceding 12 months (or for such shorter period that the registrant was
required to file such reports), and has been subject to such filing requirements
for the past 90 days. [X] Yes [ ] No


As of July 31, 1998 there were 9,599,429 shares of Summit Medical Systems, Inc.
common stock outstanding
<PAGE>

ITEM 6.  EXHIBITS AND REPORTS ON FORM 8-K

         (a)   Exhibits

   
         27.1    Financial Data Schedule - Six Months Ended June 30, 1998
                  (previously filed)

         27.2    Restated Financial Data Schedule - Six Months Ended
                  June 30, 1997 (previously filed)

         27.3    Restated Financial Data Schedule - Year Ended December 31, 1997
                  (previously filed)
    

         27.4    Restated Financial Data Schedule - Three Months Ended
                  March 31, 1996

         27.5    Restated Financial Data Schedule - Six Months Ended
                  June 30, 1996

         27.6    Restated Financial Data Schedule - Nine Months Ended
                  September 30, 1996

         27.7    Restated Financial Data Schedule - Year Ended December 31, 1996

         27.8    Restated Financial Data Schedule - Three Months Ended
                  March 31, 1997

         27.9    Restated Financial Data Schedule - Nine Months Ended
                  September 30, 1997

         27.10   Restated Financial Data Schedule - Three Months Ended
                  March 31, 1998

         (b)   Reports on Form 8-K
               None

                                       11
UNITED STATES ENVIRONMENTAL PROTECTION AGENCY

NATIONAL VEHICLE AND FUEL EMISSIONS LABORATORY

2565 PLYMOUTH ROAD

ANN ARBOR, MICHIGAN 48105-2498

 

MEMORANDUM

SUBJECT: Air Quality Modeling Materials for the final renewable fuel standard rule

FROM: Margaret Zawacki

Assessment and Standards Division

Office of Transportation and Air Quality

TO: Docket EPA-HQ-OAR-2005-0161-DRAFT-2902

DATE: January 13, 2010

The purpose of this memorandum is to transmit data files which were used in the air quality

modeling analyses for the final renewable fuel standard rule. The air quality modeling analyses 

are discussed in Section VI of the preamble, Chapter 3 of the Regulatory Impact Analysis (RIA) 

and in the Air Quality Modeling Technical Support Document. Information on the inventories is 

also discussed in Chapter 3 of the RIA. Following is a list of the information contained on the 

enclosed disc.

- 2022ci_eisa_rr_8hr_max_meshed.csv: gridded daily 8-hour ozone max outputs (BenMAP inputs) for 2022

- 2022ci_eisa_rr_MATS_PM25.csv: gridded annual SMAT'd PM2.5 species outputs (BenMAP inputs) for 2022

- ozone_DV.xls: county-level 8-hour max ozone Design Value projections for 2022

- annual_pm25_DV.xls: county-level annual PM2.5 Design Value projections for 2022

- 24hr_PM25_DV.xls: county-level 24-hour PM2.5 Design Value projections for 2022

- visibility.xls: Class 1 Area visibility projections for the 20% worst days for 2022

- deposition folder: gridded annual nitrogen and sulfur deposition data for 2022

- toxics folder: gridded annual and seasonal toxics data for 2022

- 2009 aqchem_update.pdf: Memo from Shawn Roselle and Ann Marie Carlton (August 5, 2009) on updates to the 

CMAQ aqueous phase chemistry routine (aqchem)

- met.2005.12EUS1.pdf: Baker K. and P. Dolwick. Meteorological Modeling Performance Evaluation for the 

Annual 2005 Eastern U.S. 12-km Domain Simulation, USEPA/OAQPS, February 2, 2009.

- met.2005.12WUS1.pdf: Baker K. and P. Dolwick. Meteorological Modeling Performance Evaluation for the 

Annual 2005 Western U.S. 12-km Domain Simulation, USEPA/OAQPS, February 2, 2009.

- met.2005.36US1.pdf: Baker K. and P. Dolwick. Meteorological Modeling Performance Evaluation for the Annual 

2005 Continental U.S. 36-km Domain Simulation, USEPA/OAQPS, February 2, 2009.

Attachments

OFFICE OF

AIR AND RADIATION
<TABLE> <S> <C>

<ARTICLE> 5

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-END>                               JUN-30-2000
<CASH>                                          41,494
<SECURITIES>                                         0
<RECEIVABLES>                                   57,373
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                98,867
<PP&E>                                         948,104
<DEPRECIATION>                               (510,824)
<TOTAL-ASSETS>                                 574,607
<CURRENT-LIABILITIES>                           67,911
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                           849
<OTHER-SE>                                   1,379,285
<TOTAL-LIABILITY-AND-EQUITY>                   574,607
<SALES>                                        220,830
<TOTAL-REVENUES>                               220,849
<CGS>                                           64,186
<TOTAL-COSTS>                                   64,186
<OTHER-EXPENSES>                               187,170
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                               2,452
<INCOME-PRETAX>                               (32,959)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                  (32,959)
<EPS-BASIC>                                      (.04)
<EPS-DILUTED>                                    (.04)


</TABLE>
260 La. 689

#### PALMER AND PALMER v. UNITED INVESTMENT CORPORATION d/b/a Citizens Finance Company.

No. 52072.

Supreme Court of Louisiana.

Feb. 8, 1972.

In re: Robert E. Palmer and Charles B. W. Palmer applying for certiorari or writ of review to the Court of Appeal, First Circuit, Parish of Tangipahoa. 255 So.2d 611.

Application denied; the court of appeal is correct.
# C_2021412EN.01001301.xml

| 11.10.2021 | EN | Official Journal of the European Union | C 412/13 |
| --- | --- | --- | --- |

11.10.2021

EN

Official Journal of the European Union

C 412/13

---

Order of the President of the General Court of 30 July 2021 — Puigdemont i Casamajó and Others v Parliament

(Case T-272/21 R)

(Interim relief - Institutional law - Member of Parliament - Privileges and immunities - Waiver of the parliamentary immunity of a Member of the Parliament - Application for suspension of operation of a measure - No urgency)

(2021/C 412/13)

Language of the case: English

Parties

Applicants: Carles Puigdemont i Casamajó (Waterloo, Belgium), Antoni Comín i Oliveres (Leuven, Belgium), Clara Ponsatí i Obiols (Leuven) (represented by: P. Bekaert, G. Boye, J. Costa i Rosselló and S. Bekaert, lawyers)

Defendant: European Parliament (represented by: N. Lorenz, N. Görlitz and T. Lukácsi, acting as Agents)

Intervener in support of the defendant: Kingdom of Spain (represented by: S. Centeno Huerta, acting as Agent)

Re:

Application under Articles 278 and 279 TFEU for the suspension of operation of decisions P9_TA(2021)0059, P9_TA(2021)0060 and P9_TA(2021)0061 of the Parliament of 9 March 2021 on the request for waiver of the applicants’ immunity.

Operative part of the order

| 1. | The application for interim measures is dismissed. |
| --- | --- |

1.

The application for interim measures is dismissed.

| 2. | The order of 2 June 2021, Puigdemont i Casamajó and Others v Parliament (T-272/21 R) is set aside. |
| --- | --- |

2.

The order of 2 June 2021, Puigdemont i Casamajó and Others v Parliament (T-272/21 R) is set aside.

| 3. | The costs of the main parties are reserved. |
| --- | --- |

3.

The costs of the main parties are reserved.

| 4. | The Kingdom of Spain shall bear its own costs. |
| --- | --- |

4.

The Kingdom of Spain shall bear its own costs.

---
#### The People of the State of New York, Respondent, v Andrew King, Appellant.

[655 NYS2d 432]

Appeal by the defendant from a judgment of the Supreme Court, Kings County (Brill, J.), rendered June 9, 1994, convicting him of burglary in the third degree, criminal possession of stolen property in the fifth degree, petit larceny, and criminal mischief in the fourth degree, upon a jury verdict, and imposing sentence.

Ordered that the judgment is affirmed.

Viewing the evidence in the light most favorable to the prosecution (see, *People v Contes,*60 NY2d 620), we find that it was legally sufficient to establish the defendant’s guilt beyond a reasonable doubt. Moreover, resolution of issues of credibility, including those involving eyewitness identification testimony, are questions to be determined by the jury, which saw and heard the witnesses *(see, People v Caban,*120 AD2d 603). Its determination is accorded great weight on appeal and will not be disturbed unless clearly unsupported by the record *(see, People v Garafolo,*44 AD2d 86, 88). Upon the exercise of our factual review power, we are satisfied that the verdict of guilt was not against the weight of the evidence *(see,*CPL 470.15 [5]).

The defendant’s remaining contentions are either unpreserved for appellate review or without merit. Mangano, P. J., Bracken, Rosenblatt and Miller, JJ., concur.
Exhibit 32.2



CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002



In connection with the Quarterly Report of Ambassadors International, Inc. (the Company) on Form 10-Q for the period ended March 31, 2005 as
filed with the Securities and Exchange Commission on the date hereof (the Report), the undersigned, Brian R. Schaefgen, Chief Financial Officer of the Company certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section
906 of the Sarbanes-Oxley Act of 2002, that:



| | (1) | The Report fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and
| | --- | -------------------------------------------------------------------------------------------------------------------------------------------------



| | (2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
| | --- | ----------------------------------------------------------------------------------------------------------------------------------------------------



|                         
|-------------------------
|                         
|/s/    BRIAN R.
SCHAEFGEN
|Brian R. Schaefgen       
|Chief Financial Officer  
|                         
|May 5, 2005              



The foregoing
certification is being furnished solely to accompany this Report pursuant to 18 U.S.C. §1350, and is not being filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and is not to be incorporated by reference into
any filing of the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing.
<PAGE>


                OFFICER EMPLOYMENT CONTINUATION AGREEMENT
                                           
Network Equipment Technologies, Inc. ("the Company") and the undersigned 
("Officer"), in partial consideration for their continuing officer and 
employment relationship and to encourage continued employment in the event of 
a potential Change of Control, agree as follows:

1.  In the event of Termination of Employment of Officer resulting from a 
Corporate Transaction, Change of Control or Hostile Take-Over (as those terms 
are defined in the 1993 Stock Option Plan, collectively referred to in this 
Agreement as "Change of Control") or from involuntary termination for reasons 
other than cause, the Company will provide severance benefits as follows:

         a.   one year of Officer's base salary ("salary continuance"), 
         b.   one year of Officer's variable compensation (computed using the
              mid-point of the applicable range and the company "meets plan"),
         c.   Officer level medical, dental, life and disability insurance
              during the period of salary continuance, and
         d.   vesting of outstanding stock options and restricted stock awards
              during the period of salary continuance.

2.  "Termination of Employment" of Officer occurs when one of the following 
occurs: he or she is terminated without cause, job location is changed more 
than 50 miles, his or her compensation is materially reduced or 
responsibilities are substantially altered or reduced (without express 
consent of the employee) by the Company, or by any successor to the Company 
in conjunction with or within one year after the close of a Change of Control.

3.  In the event of a Termination Of Employment in conjunction with a Change 
of Control, then vesting of outstanding stock options and restricted stock 
held by Officer shall accelerate at the time of such Termination.  All vested 
options shall be exercisable for the duration of the life of the option.

4.  In order to receive the foregoing, Officer agrees to execute the 
Company's release and non-competition agreement at the time of any such 
Termination of Employment.

Agreed this 3rd day of June, 1996.
    
NETWORK EQUIPMENT                                 Samuel H. Ezekiel        
                                                  ----------------------------

TECHNOLOGIES, INC.                                (Print Name of Officer)

BY:  /S/                                                    /S/  
   --------------------------------               ----------------------------



June 3, 1996

<PAGE>

                                       (Signature)
TITLE: President & CEO
       ----------------------------

















June 3, 1996
United States Court of Appeals

For the Eighth Circuit

___________________________

No. 12-3722

___________________________

United States of America

lllllllllllllllllllll Plaintiff - Appellee

v.

Demetrius McCalister, also known as Meechie, also known as Lil'D, also known as

Meechie Loc

lllllllllllllllllllll Defendant - Appellant

____________

 Appeal from United States District Court 

for the Eastern District of Missouri - St. Louis

____________

 Submitted: June 7, 2013

Filed: June 7, 2013 

[Unpublished]

____________

Before LOKEN, MELLOY, and BENTON, Circuit Judges.

____________

PER CURIAM.
Demetrius McCalister directly appeals the sentence the district court1

 imposed

after he pled guilty to charges involving drugs and firearms. His counsel has moved

to withdraw and has filed a brief under Anders v. California, 386 U.S. 738 (1967),

acknowledging that McCalister entered into a plea agreement containing an appeal

waiver, but arguing that the district court, having granted a downward variance,

abused its discretion by not imposing a more lenient sentence.

Upon careful review, this court concludes that the appeal waiver is enforceable. 

See United States v. Jennings, 662 F.3d 988, 990 (8th Cir. 2011) (court should enforce

appeal waiver if both waiver and plea agreement were entered into knowingly and

voluntarily, appeal is within waiver’s scope, and no miscarriage of justice would

result); see also United States v. Azure, 571 F.3d 769, 772 (8th Cir. 2009) (de novo

review of whether defendant waived right to appeal sentence). Having reviewed the

record independently under Penson v. Ohio, 488 U.S. 75 (1988), this court finds no

nonfrivolous issues outside the scope of the appeal waiver. 

The appeal is dismissed, and counsel’s motion to withdraw is granted.

______________________________

1

The Honorable Jean C. Hamilton, United States District Judge for the Eastern

District of Missouri.

-2-
Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of ViroPharma Incorporated (the Company) on Form
10-Q for the period ending June 30, 2007 as filed with the Securities and Exchange Commission on the date hereof (the Report), each of the undersigned officers of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted
pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:



| | (1) | The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
| | --- | ---------------------------------------------------------------------------------------------------------------------



| | (2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
| | --- | ----------------------------------------------------------------------------------------------------------------------------------------------------



|                                                                              
|------------------------------------------------------------------------------
|/s/ Michel de Rosen                                                           
|Michel de Rosen                                                               
|President, Chief Executive Officer and Chairman of the
Board of Directors     
|July 31, 2007                                                                 
|                                                                              
|/s/ Vincent J. Milano                                                         
|Vincent J. Milano                                                             
|Vice President, Chief Operating Officer, Chief Financial
Officer and Treasurer
|July 31, 2007
Exhibit 32

OFFICER’S CERTIFICATION PURSUANT TO 906CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,AS ADOPTED PURSUANT TOSECTION 906 OF THE SARBNES-OXLEY ACT OF 2002

In connection with the Annual Report of Electronic Systems Technology Inc. (the"Company") on Form 10KSB for the period ended December 31, 2003 as filed withthe Securities and Exchange Commission on the date hereof (the "Report"), I, TomL. Kirchner, Chief Executive Officer of the Company, and I, Jon Correio, Chief FinancialOfficer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuantto Section 906 of the Sarbanes-Oxley Act of 2002, that:The Report fully complies with the requirements of section 13(a) or 15 (d) of the      Securities Exchange Act of 1934; and
The information contained in the Report fairly presents, in all material respects, the      financial condition and result of operations of the Company.

 
/s/ TOM L KIRCHNER/s/ JON CORREIOTom L. KirchnerJon Correio
Chief Executive Officer
Chief Financial OfficerDate: 03/24/2004Date: 03/24/2004